Find a company
The national screening programme for colorectal adenocarcinoma generates millions of resected polyps that must be sent off for complex histopathological testing. Up to 99% of these are benign (hyperplastic) and the burden on pathology causes delays in return of results of up to 8 weeks. A resect and discard protocol for small hyperplastic polyps would streamline the diagnostic process, saving significant time, money and resources. A low-cost, fast and accurate biopsy triaging system has been developed to identify healthy samples and eliminate them from pathology. This project will determine whether it can be applied to colonic polyp screening.
| Project | Novel technology for screening colonic polyps and streamlining histopathology |
|---|---|
| Description |
The national screening programme for colorectal adenocarcinoma generates millions of resected polyps that must be sent off for complex histopathological testing. Up to 99% of these are benign (hyperplastic) and the burden on pathology causes delays in return of results of up to 8 weeks. A resect and discard protocol for small hyperplastic polyps would streamline the diagnostic process, saving significant time, money and resources. A low-cost, fast and accurate biopsy triaging system has been developed to identify healthy samples and eliminate them from pathology. This project will determine whether it can be applied to colonic polyp screening. |
| Funding | £ 670,716 |
| Competition | Competition 11 - Improving patient flow to maximise operational efficiency in the Acute Sector |
| Competition Date | August 2016 |
| Categories | Cancer |
| Health Innovation Network Partner | Health Innovation Oxford & Thames Valley |
| Website | http://www.beamlinediagnostics.com/ |